Welcome to our dedicated page for HMS Holdings news (Ticker: HMSY), a resource for investors and traders seeking the latest updates and insights on HMS Holdings stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect HMS Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of HMS Holdings's position in the market.
HMS Holdings Corp. (Nasdaq: HMSY) will present at the BofA Securities Health Care Conference on May 12, 2020, at 10:20 a.m. ET. The management team will provide an overview of HMS and engage in a virtual fireside chat. An audio webcast and presentation materials will be accessible on the company's website. HMS specializes in reducing healthcare costs and improving outcomes through technology, analytics, and engagement solutions, saving billions annually. For more details, visit the HMS investor site.
HMS Holdings Corp. (HMSY) reported a 15.9% increase in total revenue for Q1 2020, reaching $171.4 million, with organic growth of 8.5%. However, net income declined 35.4% to $12.7 million, or $0.14 per diluted share, owing to integration costs from the recent acquisition of Accent. Adjusted EBITDA rose 15.0% to $47.1 million, while cash and equivalents stood at $148 million. The company revised its FY 2020 guidance, anticipating total revenue to be between $690 million and $705 million, indicating a growth of 12.1% to 14.5%.
Summary not available.